Staphylococcus aureus with an erm-mediated constitutive macrolide-lincosamide-streptogramin B resistance phenotype has reduced susceptibility to the new ketolide, solithromycin.

MLA

Yao, Weiming, et al. “Staphylococcus Aureus with an Erm-Mediated Constitutive Macrolide-Lincosamide-Streptogramin B Resistance Phenotype Has Reduced Susceptibility to the New Ketolide, Solithromycin.” BMC Infectious Diseases, vol. 19, no. 1, Feb. 2019, p. N.PAG. EBSCOhost, https://doi.org/10.1186/s12879-019-3779-8.

APA

Yao, W., Xu, G., Li, D., Bai, B., Wang, H., Cheng, H., Zheng, J., Sun, X., Lin, Z., Deng, Q., & Yu, Z. (2019). Staphylococcus aureus with an erm-mediated constitutive macrolide-lincosamide-streptogramin B resistance phenotype has reduced susceptibility to the new ketolide, solithromycin. BMC Infectious Diseases, 19(1), N.PAG. https://doi.org/10.1186/s12879-019-3779-8

Chicago

Yao, Weiming, Guangjian Xu, Duoyun Li, Bing Bai, Hongyan Wang, Hang Cheng, Jinxin Zheng, et al. 2019. “Staphylococcus Aureus with an Erm-Mediated Constitutive Macrolide-Lincosamide-Streptogramin B Resistance Phenotype Has Reduced Susceptibility to the New Ketolide, Solithromycin.” BMC Infectious Diseases 19 (1): N.PAG. doi:10.1186/s12879-019-3779-8.